Vikas Ostwal Selected Research

Vikas Ostwal Research Topics

Disease

32	Neoplasms (Cancer) 01/2024 - 01/2016
18	Rectal Neoplasms (Rectal Cancer) 01/2024 - 07/2015
16	Adenocarcinoma 01/2024 - 02/2016
13	Gallbladder Neoplasms (Gallbladder Cancer) 10/2023 - 09/2016
12	Neoplasm Metastasis (Metastasis) 06/2023 - 04/2017
9	Colorectal Neoplasms (Colorectal Cancer) 06/2023 - 07/2015
9	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2022 - 06/2016
8	Stomach Neoplasms (Stomach Cancer) 04/2024 - 03/2017
5	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 10/2017
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2022 - 08/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2017
4	Vomiting 10/2020 - 01/2020
3	Colonic Neoplasms (Colon Cancer) 01/2024 - 01/2016
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2023 - 10/2020
3	Hand-Foot Syndrome 01/2022 - 01/2016
3	Liver Neoplasms (Liver Cancer) 03/2021 - 10/2017
3	Nausea 10/2020 - 01/2020
2	Febrile Neutropenia 09/2023 - 04/2022
2	Neutropenia 09/2023 - 12/2018
2	Infections 06/2023 - 01/2017
2	Margins of Excision 10/2022 - 09/2019
2	Diarrhea 04/2022 - 10/2020
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 10/2020
2	Sarcoma (Soft Tissue Sarcoma) 03/2017 - 03/2017
1	Fibroma (Fibromatosis) 05/2024
1	Aggressive Fibromatosis (Desmoid) 05/2024
1	Alopecia (Baldness) 10/2023
1	Thrombosis (Thrombus) 09/2023
1	Primitive Neuroectodermal Tumors (PNET) 05/2023
1	Anastomotic Leak 10/2022
1	Hemorrhage 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Lymphadenopathy 12/2021
1	Signet Ring Cell Carcinoma 12/2021
1	Disease Progression 03/2021
1	COVID-19 12/2020
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Cholangiocarcinoma 10/2020

Drug/Important Bio-Agent (IBA)

10	Capecitabine (Xeloda)FDA Link 09/2023 - 01/2016
9	Gemcitabine FDA Link 11/2023 - 04/2017
7	Radioisotopes (Radionuclides)IBA 11/2021 - 10/2016
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2023 - 03/2017
6	Peptide Receptors (Peptide Receptor)IBA 11/2021 - 10/2016
4	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 05/2017
4	Fluorouracil (Carac)FDA LinkGeneric 09/2023 - 01/2016
4	Docetaxel (Taxotere)FDA Link 09/2023 - 01/2018
4	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 08/2016
3	folfirinoxIBA 01/2024 - 12/2016
3	Epirubicin (Ellence)FDA LinkGeneric 09/2023 - 03/2017
3	Leucovorin (Folinic Acid)FDA Link 09/2023 - 10/2018
3	PlatinumIBA 06/2023 - 09/2012
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 09/2012
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2022 - 01/2021
3	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2022 - 06/2016
2	130-nm albumin-bound paclitaxelIBA 06/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 02/2019
2	Sorafenib (BAY 43-9006)FDA Link 11/2022 - 10/2017
2	MucinsIBA 12/2021 - 09/2019
2	lutetium Lu 177 dotatateIBA 11/2021 - 12/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2021 - 10/2018
2	AntiemeticsIBA 10/2020 - 10/2020
2	regorafenibIBA 01/2019 - 02/2016
2	pazopanib FDA Link 01/2019 - 08/2016
1	ErbB Receptors (EGF Receptor)IBA 11/2023
1	human ERBB2 proteinIBA 11/2023
1	Trastuzumab (Herceptin)FDA Link 11/2023
1	Cytidine Triphosphate (CTP)IBA 09/2023
1	Immune Checkpoint InhibitorsIBA 09/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2022
1	Serum AlbuminIBA 12/2022
1	ResveratrolIBA 11/2022
1	CopperIBA 11/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022
1	Metformin (Glucophage)FDA LinkGeneric 11/2022
1	Atorvastatin (Lipitor)FDA Link 11/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	RamucirumabIBA 01/2022
1	Trinitrotoluene (TNT)IBA 12/2021
1	SolutionsIBA 12/2021
1	AntigensIBA 12/2021
1	Yttrium-90IBA 03/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	SDMIBA 10/2020

Therapy/Procedure

45	Drug Therapy (Chemotherapy) 04/2024 - 09/2012
30	Therapeutics 05/2024 - 07/2015
18	Neoadjuvant Therapy 04/2024 - 07/2015
9	Adjuvant Chemotherapy 01/2022 - 09/2012
7	Radiotherapy 10/2022 - 01/2017
6	Chemoradiotherapy 10/2022 - 12/2016
3	Lymph Node Excision (Lymph Node Dissection) 01/2024 - 06/2020
3	Length of Stay 10/2022 - 07/2015
1	Immunotherapy 09/2023
1	Hyperthermic Intraperitoneal Chemotherapy 06/2023
1	Pancreatectomy 05/2023
1	Gastrectomy 01/2022
1	Reoperation 10/2021
1	Consolidation Chemotherapy 05/2021
1	Pelvic Exenteration 05/2021
1	capecitabine-irinotecan combination 03/2021